The aging brain accumulates dysfunctional neurons not because it actively prunes inefficient cells, but because senescent glia lose the ability to recognize a metabolic “eat‑me” signal on stressed neurons. We propose that neurons facing energy deficit expose surface phosphatidylserine (PS) in proportion to their ATP/AMP ratio, a signal normally sensed by glial TREM2 and CX3CR1 receptors to trigger phagocytosis. In young tissue, this coupling ensures rapid removal of metabolically compromised neurons, preserving network efficiency. With age, glial senescence downregulates TREM2/CX3CR1 expression and impairs lysosomal acidification, uncoupling PS exposure from engulfment. Consequently, neurons that would be cleared persist, release SASP, and fuel a vicious cycle of glial reactivity and further neuronal stress.
This hypothesis generates clear, testable predictions. First, pharmacological elevation of neuronal AMP‑activated protein kinase (AMPK) should increase surface PS on neurons in vitro, measurable by Annexin V‑flow cytometry. Second, blocking TREM2 or CX3CR1 on microglia will abolish the phagocytic response to AMPK‑activated neurons despite high PS exposure. Third, in aged mice, senolytic clearance of p16^high^ glia followed by an AMPK activator (e.g., AICAR) will restore glial phagocytic flux, reduce Annexin V^+^ neuron burden, and improve cognitive performance relative to senolytics alone. Fourth, sex‑dependent efficacy observed with ABT263 may stem from baseline differences in glial AMPK activity; measuring p‑AMPK in isolated microglia should predict senolytic respons





























